Spire Wealth Management Gsk PLC Transaction History

Spire Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$42.05 - $47.77 $75,900 - $86,224	-1,805 Reduced 15.43%	9,890 $431,000
Q1 2022 Apr 18, 2022	SELL	$40.23 - $47.74 $101,942 - $120,973	-2,534 Reduced 17.81%	11,695 $509,000
Q4 2021 Jan 14, 2022	BUY	$38.88 - $45.31 $77,215 - $89,985	1,986 Added 16.22%	14,229 $628,000
Q3 2021 Oct 22, 2021	BUY	$38.79 - $43.16 $61,055 - $67,933	1,574 Added 14.75%	12,243 $468,000
Q2 2021 Jul 26, 2021	SELL	$36.52 - $41.46 $187,603 - $212,980	-5,137 Reduced 32.5%	10,669 $425,000
Q1 2021 May 21, 2021	BUY	$34.27 - $40.01 $541,671 - $632,398	15,806 New	15,806 $566,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.